Iris Scherwitzl

662 total citations
6 papers, 114 citations indexed

About

Iris Scherwitzl is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Iris Scherwitzl has authored 6 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Immunology. Recurrent topics in Iris Scherwitzl's work include CAR-T cell therapy research (3 papers), Virus-based gene therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Iris Scherwitzl is often cited by papers focused on CAR-T cell therapy research (3 papers), Virus-based gene therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Iris Scherwitzl collaborates with scholars based in United Kingdom, United States and Thailand. Iris Scherwitzl's co-authors include Gavin Screaton, Daniel Meruelo, Silvana Opp, Alicia Hurtado, Christine Pampeno, Minjun Yu, Sandra Vogt, Aristotelis Tsirigos, Cher‐Pheng Ooi and Sophie Ridewood and has published in prestigious journals such as Molecular Microbiology, Virus Research and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Iris Scherwitzl

6 papers receiving 111 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris Scherwitzl United Kingdom	5	49	45	31	31	29	6	114
Shulong Zu China	8	77 1.6×	84 1.9×	44 1.4×	35 1.1×	65 2.2×	13	177
Duncan Bellamy United Kingdom	8	23 0.5×	59 1.3×	30 1.0×	34 1.1×	62 2.1×	15	124
Xianmiao Ye China	9	40 0.8×	102 2.3×	71 2.3×	20 0.6×	49 1.7×	13	190
Marinela Kirilova United States	4	20 0.4×	32 0.7×	19 0.6×	42 1.4×	19 0.7×	4	99
Lily Parenteau United States	4	12 0.2×	50 1.1×	36 1.2×	67 2.2×	35 1.2×	4	126
Rouzbeh Zamani United States	6	41 0.8×	81 1.8×	14 0.5×	14 0.5×	29 1.0×	7	132
Maurizio Gramegna Italy	7	58 1.2×	82 1.8×	34 1.1×	8 0.3×	60 2.1×	14	198
Ryan Swanson United States	5	26 0.5×	58 1.3×	18 0.6×	23 0.7×	106 3.7×	11	223
Matthew B. McDougal United States	6	21 0.4×	59 1.3×	9 0.3×	81 2.6×	37 1.3×	7	171
R. Blake Richardson United States	5	106 2.2×	110 2.4×	10 0.3×	64 2.1×	75 2.6×	6	229

Countries citing papers authored by Iris Scherwitzl

Since Specialization

Citations

This map shows the geographic impact of Iris Scherwitzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Scherwitzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Scherwitzl more than expected).

Fields of papers citing papers by Iris Scherwitzl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Scherwitzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Scherwitzl. The network helps show where Iris Scherwitzl may publish in the future.

Co-authorship network of co-authors of Iris Scherwitzl

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Scherwitzl. A scholar is included among the top collaborators of Iris Scherwitzl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Scherwitzl. Iris Scherwitzl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Scherwitzl, Iris, Piyada Supasa, Wanwisa Dejnirattisai, et al.. (2024). The alteration of NK cells phenotypes related to the functions and dengue disease outcomes. Virus Research. 345. 199382–199382. 2 indexed citations

2.

Scherwitzl, Iris, Silvana Opp, Alicia Hurtado, et al.. (2020). Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors. Molecular Therapy — Oncolytics. 17. 431–447. 13 indexed citations

3.

Yu, Minjun, Iris Scherwitzl, Silvana Opp, Aristotelis Tsirigos, & Daniel Meruelo. (2019). Molecular and metabolic pathways mediating curative treatment of a non-Hodgkin B cell lymphoma by Sindbis viral vectors and anti-4-1BB monoclonal antibody. Journal for ImmunoTherapy of Cancer. 7(1). 185–185. 16 indexed citations

4.

Scherwitzl, Iris, et al.. (2018). Systemically Administered Sindbis Virus in Combination with Immune Checkpoint Blockade Induces Curative Anti-tumor Immunity. Molecular Therapy — Oncolytics. 9. 51–63. 21 indexed citations

5.

Scherwitzl, Iris, et al.. (2017). Recent advances in human flavivirus vaccines. Current Opinion in Virology. 23. 95–101. 37 indexed citations

6.

Ridewood, Sophie, et al.. (2017). The role of genomic location and flanking 3′UTR in the generation of functional levels of variant surface glycoprotein in Trypanosoma brucei. Molecular Microbiology. 106(4). 614–634. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact